Potential of noninvasive serial assessment of acute renal allograft rejection by18F-FDG PET to monitor treatment efficiency

Journal of Nuclear Medicine

Volumn 51, Issue 10, 2010, Pages 1644-1652

  Reuter, Stefan ^a   Schnöckel, Uta ^a   Edemir, Bayram ^a   Schröter, Rita ^a   Kentrup, Dominik ^a   Pavenstädt, Hermann ^a   Schober, Otmar ^a   Schlatter, Eberhard ^a   Gabriëls, Gert ^a   Schäfers, Michael ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

18F FDG PET; Acute rejection; Renal transplantation

Indexed keywords

CREATININE; CYCLOSPORIN A; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ACUTE KIDNEY TUBULE NECROSIS; ACUTE RENAL ALLOGRAFT REJECTION; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOTOXIC T LYMPHOCYTE; GLUCOSE METABOLISM; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INFLAMMATORY INFILTRATE; KIDNEY ALLOGRAFT REJECTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MACROPHAGE; MONOCYTE; NEPHROTOXICITY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOACTIVITY; RAT; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT RESPONSE;

ACUTE DISEASE; ANIMALS; FEASIBILITY STUDIES; FLUORODEOXYGLUCOSE F18; GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RATS; RATS, INBRED LEW; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 79851482770     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.078550     Document Type: Article

References (37)

1. Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation. 1994;57:857-859. (Pubitemid 24114677)
2. Meier-Kriesche HU, Ojo AO, Hanson JA, et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation. 2000;70:1098-1100.
3. Opelz G, Dohler B. Influence of time of rejection on long-term graft survival in renal transplantation. Transplantation. 2008;85:661-666. (Pubitemid 351398238)
4. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol. 2005;16:3015-3026. (Pubitemid 44743499)
5. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605-612.
6. Massy ZA, Guijarro C, Wiederkehr MR, Ma JZ, Kasiske BL. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int. 1996;49:518-524. (Pubitemid 26051834)
7. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55:713-723. (Pubitemid 29082898)
8. Rush D. Protocol transplant biopsies: an underutilized tool in kidney transplantation. Clin J Am Soc Nephrol. 2006;1:138-143.
9. Morath C, Ritz E, Zeier M. Protocol biopsy: what is the rationale and what is the evidence? Nephrol Dial Transplant. 2003;18:644-647.
10. El-Mekresh M, Osman Y, Ii-El-Dein B, El-Diasty T, Ghoneim MA. Urological complications after living-donor renal transplantation. BJU Int. 2001;87:295-306.
11. Schwarz A, Hiss M, Gwinner W, Becker T, Haller H, Keberle M. Course and relevance of arteriovenous fistulas after renal transplant biopsies. Am J Transplant. 2008;8:826-831. (Pubitemid 351347768)
12. Guttmann RD, Soulillou JP, Moore LW, et al. Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejection. Am J Kidney Dis. 1998;31(6, suppl 1)S40-S46. (Pubitemid 28265215)
13. Guttmann RD, Soulillou JP. Definitions of acute rejection and controlled clinical trials in the medical literature. Am J Kidney Dis. 1998;31(6, suppl 1)S3-S6. (Pubitemid 28265209)
14. Becker YT, Becker BN, Pirsch JD, Sollinger HW. Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant. 2004;4:996-1001. (Pubitemid 38745599)
15. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35-45. (Pubitemid 47555372)
16. Reuter S, Schnöckel U, Schröter R, et al. Non-invasive imaging of acute renal allograft rejection in rats using small animal 18F-FDG-PET. PLoS ONE. 2009;4:e5296.
17. 1H). Clin J Am Soc Nephrol. 2006;1:539-545.
18. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med. 2003;349:125-138. (Pubitemid 36818782)
19. Edemir B, Reuter S, Borgulya R, et al. Acute rejection modulates gene expression in the collecting duct. J Am Soc Nephrol. 2008;19:538-546. (Pubitemid 351355397)
20. Reuter S, Velic A, Edemir B, et al. Protective role of NHE-3 inhibition in rat renal transplantation undergoing acute rejection. Pflugers Arch. 2008;456:1075-1084.
21. Schnöckel U, Reuter S, Stegger L, et al. Dynamic 18F-fluoride small animal PET to noninvasively assess renal function in rats. Eur J Nucl Med Mol Imaging. 2008;35:2267-2274.
22. Schäfers KP, Reader AJ, Kriens M, Knoess C, Schober O, Schafers M. Performance evaluation of the 32-module quadHIDAC small-animal PET scanner. J Nucl Med. 2005;46:996-1004. (Pubitemid 43733515)
23. Reader AJ, Ally S, Bakatselos F. One-pass list-mode EM algorithm for high resolution 3D PET image reconstruction into large arrays. IEEE Trans Nucl Sci. 2002;49:693-699. (Pubitemid 35311888)
24. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8:753-760. (Pubitemid 351347767)
25. Sis B, Sarioglu S, Celik A, et al. Renal medullary changes in renal allograft recipients with raised serum creatinine. J Clin Pathol. 2006;59:377-381.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408. (Pubitemid 34164012)
27. Kaim AH, Weber B, Kurrer MO, Gottschalk J, Von Schulthess GK, Buck A. Autoradiographic quantification of 18F-FDG uptake in experimental soft-tissue abscesses in rats. Radiology. 2002;223:446-451. (Pubitemid 34454324)
28. Edemir B, Kurian SM, Eisenacher M, et al. Activation of counter-regulatory mechanisms in a rat renal acute rejection model. BMC Genomics. 2008;9:71.
29. Nickeleit V, Andreoni K. Inflammatory cells in renal allografts. Front Biosci. 2008;13:6202-6213.
30. 18F-FDG-labeled white blood cells versus 18F-FDG. J Nucl Med. 2005;46:1522-1530.
31. Reuter S, Bangen P, Edemir B, et al. The HSP72 stress response of monocytes from patients on haemodialysis is impaired. Nephrol Dial Transplant. 2009;24:2838-2846.
32. Hoff SJ, Stewart JR, Frist WH, et al. Noninvasive detection of heart transplant rejection with positron emission scintigraphy. Ann Thorac Surg. 1992;53:572-577.
33. Tsuji AB, Morita M, Li XK, et al. 18F-FDG PET for semiquantitative evaluation of acute allograft rejection and immunosuppressive therapy efficacy in rat models of liver transplantation. J Nucl Med. 2009;50:827-830.
34. 18F] fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography. Transplantation. 1998;66:1101-1103.
35. Shapiro R, Randhawa P, Jordan ML, et al. An analysis of early renal transplant protocol biopsies: the high incidence of subclinical tubulitis. Am J Transplant. 2001;1:47-50. (Pubitemid 33681680)
36. 99mTc- mononuclear leukocyte imaging. Transplant Proc. 2004;36:2997-3001.
37. Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. J Nucl Med. 2007;48:764-770. (Pubitemid 47604977)